131 related articles for article (PubMed ID: 31955885)
1. Salinomycin and dichloroacetate synergistically inhibit Lewis lung carcinoma cell proliferation, tumor growth and metastasis.
Skeberdytė A; Sarapinienė I; Krasko JA; Barakauskienė A; Žilionytė K; Prokarenkaitė R; Sužiedėlis K; Bukelskienė V; Jarmalaitė S
Biochem Biophys Res Commun; 2020 Mar; 523(4):874-879. PubMed ID: 31955885
[TBL] [Abstract][Full Text] [Related]
2. Dichloroacetate and Salinomycin Exert a Synergistic Cytotoxic Effect in Colorectal Cancer Cell Lines.
Skeberdytė A; Sarapinienė I; Aleksander-Krasko J; Stankevičius V; Sužiedėlis K; Jarmalaitė S
Sci Rep; 2018 Dec; 8(1):17744. PubMed ID: 30531808
[TBL] [Abstract][Full Text] [Related]
3. Targeting breast cancer stem cells in triple-negative breast cancer using a combination of LBH589 and salinomycin.
Kai M; Kanaya N; Wu SV; Mendez C; Nguyen D; Luu T; Chen S
Breast Cancer Res Treat; 2015 Jun; 151(2):281-94. PubMed ID: 25904215
[TBL] [Abstract][Full Text] [Related]
4. Metformin enhances cytotoxic action of dichloroacetate against Lewis lung carcinoma cells in vitro.
Kolesnik DL; Pyaskovskaya ON; Gorbach O; Solyanik GI
Exp Oncol; 2020 Mar; 42(1):35-39. PubMed ID: 32231186
[TBL] [Abstract][Full Text] [Related]
5. 2-Deoxy-D-glucose enhances dichloroacetate antitumor action against Lewis lung carcinoma.
Pyaskovskaya ON; Kolesnik DL; Fedorchuk AG; Prokhorova IV; Solyanik GI
Exp Oncol; 2016 Sep; 38(3):176-80. PubMed ID: 27685525
[TBL] [Abstract][Full Text] [Related]
6. Salinomycin effectively eliminates cancer stem-like cells and obviates hepatic metastasis in uveal melanoma.
Zhou J; Liu S; Wang Y; Dai W; Zou H; Wang S; Zhang J; Pan J
Mol Cancer; 2019 Nov; 18(1):159. PubMed ID: 31718679
[TBL] [Abstract][Full Text] [Related]
7. Salinomycin suppresses cancer cell stemness and attenuates TGF-β-induced epithelial-mesenchymal transition of renal cell carcinoma cells.
Liu L; Wang Q; Mao J; Qin T; Sun Y; Yang J; Han Y; Li L; Li Q
Chem Biol Interact; 2018 Dec; 296():145-153. PubMed ID: 30273566
[TBL] [Abstract][Full Text] [Related]
8. Silencing stem cell factor attenuates stemness and inhibits migration of cancer stem cells derived from Lewis lung carcinoma cells.
Wang L; Wang J; Li Z; Liu Y; Jiang M; Li Y; Cao D; Zhao M; Wang F; Luo F
Tumour Biol; 2016 Jun; 37(6):7213-27. PubMed ID: 26666817
[TBL] [Abstract][Full Text] [Related]
9. Effect of dichloroacetate on Lewis lung carcinoma growth and metastasis.
Kolesnik DL; Pyaskovskaya ON; Boychuk IV; Dasyukevich OI; Melnikov OR; Tarasov AS; Solyanik GI
Exp Oncol; 2015 Jun; 37(2):126-9. PubMed ID: 26112940
[TBL] [Abstract][Full Text] [Related]
10. The inhibitory effect of salinomycin on the proliferation, migration and invasion of human endometrial cancer stem-like cells.
Kusunoki S; Kato K; Tabu K; Inagaki T; Okabe H; Kaneda H; Suga S; Terao Y; Taga T; Takeda S
Gynecol Oncol; 2013 Jun; 129(3):598-605. PubMed ID: 23500085
[TBL] [Abstract][Full Text] [Related]
11. Semi-synthetic salinomycin analogs exert cytotoxic activity against human colorectal cancer stem cells.
Klose J; Kattner S; Borgström B; Volz C; Schmidt T; Schneider M; Oredsson S; Strand D; Ulrich A
Biochem Biophys Res Commun; 2018 Jan; 495(1):53-59. PubMed ID: 29107689
[TBL] [Abstract][Full Text] [Related]
12. Dichloroacetate and PX-478 exhibit strong synergistic effects in a various number of cancer cell lines.
Parczyk J; Ruhnau J; Pelz C; Schilling M; Wu H; Piaskowski NN; Eickholt B; Kühn H; Danker K; Klein A
BMC Cancer; 2021 Apr; 21(1):481. PubMed ID: 33931028
[TBL] [Abstract][Full Text] [Related]
13. Differential effects of drugs targeting cancer stem cell (CSC) and non-CSC populations on lung primary tumors and metastasis.
Larzabal L; El-Nikhely N; Redrado M; Seeger W; Savai R; Calvo A
PLoS One; 2013; 8(11):e79798. PubMed ID: 24278179
[TBL] [Abstract][Full Text] [Related]
14. Superior anti-tumor efficacy of diisopropylamine dichloroacetate compared with dichloroacetate in a subcutaneous transplantation breast tumor model.
Su L; Zhang H; Yan C; Chen A; Meng G; Wei J; Yu D; Ding Y
Oncotarget; 2016 Oct; 7(40):65721-65731. PubMed ID: 27582548
[TBL] [Abstract][Full Text] [Related]
15. Salinomycin enhances doxorubicin sensitivity through reversing the epithelial-mesenchymal transition of cholangiocarcinoma cells by regulating ARK5.
Yu Z; Cheng H; Zhu H; Cao M; Lu C; Bao S; Pan Y; Li Y
Braz J Med Biol Res; 2017 Aug; 50(10):e6147. PubMed ID: 28832761
[TBL] [Abstract][Full Text] [Related]
16. Anti-cancer synergy of dichloroacetate and EGFR tyrosine kinase inhibitors in NSCLC cell lines.
Yang Z; Tam KY
Eur J Pharmacol; 2016 Oct; 789():458-467. PubMed ID: 27514773
[TBL] [Abstract][Full Text] [Related]
17. Salinomycin inhibits the growth of colorectal carcinoma by targeting tumor stem cells.
Zhang C; Tian Y; Song F; Fu C; Han B; Wang Y
Oncol Rep; 2015 Nov; 34(5):2469-76. PubMed ID: 26352531
[TBL] [Abstract][Full Text] [Related]
18. Metabolic Modulation of Clear-cell Renal Cell Carcinoma with Dichloroacetate, an Inhibitor of Pyruvate Dehydrogenase Kinase.
Kinnaird A; Dromparis P; Saleme B; Gurtu V; Watson K; Paulin R; Zervopoulos S; Stenson T; Sutendra G; Pink DB; Carmine-Simmen K; Moore R; Lewis JD; Michelakis ED
Eur Urol; 2016 Apr; 69(4):734-744. PubMed ID: 26433571
[TBL] [Abstract][Full Text] [Related]
19. Salinomycin inhibits growth of pancreatic cancer and cancer cell migration by disruption of actin stress fiber integrity.
Schenk M; Aykut B; Teske C; Giese NA; Weitz J; Welsch T
Cancer Lett; 2015 Mar; 358(2):161-169. PubMed ID: 25529011
[TBL] [Abstract][Full Text] [Related]
20. Salinomycin reduces epithelial-mesenchymal transition-mediated multidrug resistance by modifying long noncoding RNA HOTTIP expression in gastric cancer cells.
Mao Z; Wu Y; Zhou J; Xing C
Anticancer Drugs; 2019 Oct; 30(9):892-899. PubMed ID: 30882398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]